Mayo Clinic Talks cover image

Mild Cognitive Impairment

Mayo Clinic Talks

00:00

Treatment Options: Symptomatic and Disease‑Modifying

Dr. Petersen contrasts symptomatic drugs (not FDA‑approved for MCI) with anti-amyloid monoclonal antibodies that reduce amyloid and slow decline.

Play episode from 20:50
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app